S&P 500 7,510.38 â–ŧ 43.91 (-0.58%) DOW 51,995.32 ▲ 324.29 (+0.63%) NASDAQ 26,374.22 â–ŧ 309.73 (-1.16%) US Markets Closed â€ĸ 04:34 PM ET

RNLXY

Renalytix Plc

Price Chart
Latest Quote

$1.19

+0.01 (+0.51%)
Current Price
Previous Close $1.19
Open $1.11
Day High $1.11
Day Low $1.11
Volume 4
Fetched: 2026-06-16T05:22:12
Stock Information
Shares Outstanding 218.51M
Total Debt $5.80M
Cash Equivalents $6.20M
Revenue $3.30M
Net Income $-19.90M
Market Cap $260.90M
EPS (TTM) $-3.50
Exchange OQB
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$10.04M
Sales$3.30M
Income$-19.90M
Book/sh$-0.15
Cash/sh$0.03
Employees46
Financial Ratios
Quick Ratio1.39
Current Ratio1.57
Returns & Margins
Gross Margin45.46%
Operating Margin-437.50%
Ownership
Insider Ownership1.07%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E-6.28
P/S79.06
P/B-7.96
Analyst Data
Recommendationnone
Technical Indicators
SMA20$1.25
SMA50$1.28
SMA200$51.42
RSI46.48
ATR0.1105
Shares Float7.28M
Volatility1.81
Rel Volume0.16
Performance History
Week-0.91%
Month-1.32%
Quarter-42.32%
6 Months-98.91%
YTD-70.08%
Year-98.94%
3 Years-99.91%
5 Years-99.99%
10 Years-99.99%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-15 $1.19 500
2026-06-12 $1.25 400
2026-06-11 $1.19 3,100
2026-06-10 $1.28 1,000
2026-06-09 $1.23 300
2026-06-08 $1.21 0
2026-06-05 $1.21 600
2026-06-04 $1.30 200
2026-06-03 $1.35 2,000
2026-06-02 $1.23 12,500
2026-06-01 $1.29 1,400
2026-05-29 $1.33 700
2026-05-28 $1.29 16,900
2026-05-27 $1.22 4,700
2026-05-26 $1.25 1,300
2026-05-22 $1.18 1,700
2026-05-21 $1.26 2,100
2026-05-20 $1.20 2,100
2026-05-19 $1.22 2,600
2026-05-18 $1.23 8,000
About Renalytix Plc

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score. The company's products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. It has a license agreement with Mount Sinai Health System to develop and commercialize its products in connection with the application of artificial intelligence for the diagnosis of kidney disease. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. The company was incorporated in 2018 and is based in London, the United Kingdom.

Period:
Loading...
Income Statement (Annual)
Metric 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Revenue
Reconciled Cost Of Revenue $1,800,000 $2,100,000 $2,683,000 $2,096,000
Cost Of Revenue $1,800,000 $2,100,000 $2,683,000 $2,096,000
Total Revenue $3,000,000 $2,300,000 $3,403,000 $2,970,000
Operating Revenue $3,000,000 $2,300,000 $3,403,000 $2,970,000
Expenses
Interest Expense $500,000 $0 - $2,000
Total Expenses $20,200,000 $32,800,000 $45,624,000 $56,153,000
Rent Expense Supplemental $400,000 $300,000 - -
Net Non Operating Interest Income Expense $-400,000 $-400,000 - $-40,000
Total Other Finance Cost $-100,000 $600,000 - $50,000
Interest Expense Non Operating $500,000 $0 - $2,000
Operating Expense $18,400,000 $30,700,000 $42,941,000 $54,057,000
Selling And Marketing Expense $400,000 $700,000 - -
General And Administrative Expense $4,900,000 $10,800,000 $28,662,000 $39,524,000
Other Non Operating Income Expenses - $249,000 $656,000 $131,000
Other Operating Expenses - - - $10,313,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-20,400,000 $-45,500,000 $-45,607,000 $-45,276,000
Net Interest Income $-400,000 $-400,000 - $-40,000
Interest Income $0 $200,000 - $12,000
Normalized Income $-16,188,991 $-30,700,000 $-41,218,000 $-43,735,380
Net Income From Continuing And Discontinued Operation $-20,400,000 $-45,500,000 $-45,607,000 $-45,276,000
Total Operating Income As Reported $-17,200,000 $-30,500,000 $-42,221,000 $-53,183,000
Net Income Common Stockholders $-20,400,000 $-45,500,000 $-45,607,000 $-45,276,000
Net Income $-20,400,000 $-45,500,000 $-45,607,000 $-45,276,000
Net Income Including Noncontrolling Interests $-20,400,000 $-45,500,000 $-45,607,000 $-45,276,000
Net Income Continuous Operations $-20,400,000 $-45,500,000 $-45,607,000 $-45,276,000
Pretax Income $-21,800,000 $-45,500,000 $-45,605,000 $-45,251,000
Special Income Charges $-3,500,000 $-10,500,000 $0 $0
Interest Income Non Operating $0 $200,000 - $12,000
Operating Income $-17,200,000 $-30,500,000 $-42,221,000 $-53,183,000
Depreciation And Amortization In Income Statement $0 $2,000,000 - $2,254,000
Depreciation Income Statement $0 $2,000,000 - $2,254,000
Gross Profit $1,200,000 $200,000 $720,000 $874,000
Per Share
Diluted EPS - $-15.50 $-28.00 $-41.00
Basic EPS - $-15.50 $-28.00 $-39.00
Other
Tax Effect Of Unusual Items $-288,991 $0 $0 $-361,380
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-16,800,000 $-28,200,000 $-37,324,000 $-50,792,000
Total Unusual Items $-4,500,000 $-14,800,000 $-4,389,000 $-1,902,000
Total Unusual Items Excluding Goodwill $-4,500,000 $-14,800,000 $-4,389,000 $-1,902,000
Reconciled Depreciation $0 $2,500,000 $508,000 $489,000
EBITDA (Bullshit earnings) $-21,300,000 $-43,000,000 $-41,713,000 $-52,694,000
EBIT $-21,300,000 $-45,500,000 $-42,221,000 $-53,183,000
Diluted NI Availto Com Stockholders $-20,400,000 $-45,500,000 $-45,607,000 $-45,276,000
Otherunder Preferred Stock Dividend $0 $0 $0 $0
Tax Provision $-1,400,000 $0 $2,000 $25,000
Other Special Charges $3,500,000 - - $-115,000
Impairment Of Capital Assets $0 $10,500,000 $0 -
Research And Development $900,000 $5,100,000 $14,298,000 $14,648,000
Selling General And Administration $5,300,000 $11,500,000 $28,662,000 $39,524,000
Diluted Average Shares - $2,163,587 $1,644,201 $1,457,225
Basic Average Shares - $2,163,587 $1,644,201 $1,457,225
Minority Interests - - - $0
Write Off - - - $0
Fetched: 2026-02-02
Balance Sheet (Annual)
Metric 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Assets
Net Tangible Assets $-7,000,000 $-9,000,000 $6,967,000 $30,607,000
Total Assets $6,100,000 $7,100,000 $30,629,000 $50,065,000
Total Non Current Assets $300,000 $300,000 $3,747,000 $5,311,000
Other Non Current Assets $100,000 $100,000 $1,101,000 $1,189,000
Goodwill And Other Intangible Assets $0 $0 - $14,020,000
Current Assets $5,800,000 $6,800,000 $26,882,000 $44,754,000
Other Current Assets $100,000 $100,000 $1,424,000 $2,445,000
Prepaid Assets $600,000 $300,000 - $1,257,000
Inventory $200,000 $300,000 - $1,160,000
Taxes Receivable $600,000 $0 - -
Accounts Receivable $600,000 $700,000 $776,000 $901,000
Cash Cash Equivalents And Short Term Investments $3,700,000 $5,400,000 $24,682,000 $41,333,000
Cash And Cash Equivalents $3,600,000 $4,700,000 $24,682,000 $41,333,000
Cash Financial $3,600,000 $4,700,000 $24,682,000 $41,333,000
Investmentin Financial Assets - $698,000 $1,460,000 $2,744,000
Allowance For Doubtful Accounts Receivable - $-100,000 $-100,000 -
Gross Accounts Receivable - $822,000 $876,000 $901,000
Non Current Deferred Taxes Assets - - - $0
Other Intangible Assets - - - $14,020,000
Current Deferred Assets - - - $36,000
Other Receivables - - - $75,000
Assets Held For Sale Current - - - -
Debt
Net Debt $4,700,000 $3,800,000 - -
Total Debt $8,300,000 $8,500,000 $12,119,000 $12,342,000
Long Term Debt And Capital Lease Obligation $8,300,000 $4,300,000 $7,526,000 $7,682,000
Long Term Debt $8,300,000 $4,300,000 $7,485,000 $7,682,000
Current Debt And Capital Lease Obligation $0 $4,200,000 $4,593,000 $4,660,000
Current Debt $0 $4,200,000 $4,463,000 $4,660,000
Liabilities
Total Liabilities Net Minority Interest $13,100,000 $16,100,000 $23,662,000 $19,458,000
Total Non Current Liabilities Net Minority Interest $8,300,000 $4,300,000 $7,526,000 $7,682,000
Current Liabilities $4,800,000 $11,800,000 $16,136,000 $11,776,000
Payables $2,700,000 $2,800,000 $2,936,000 $2,514,000
Total Tax Payable $100,000 $200,000 - $139,000
Accounts Payable $2,600,000 $2,600,000 $2,936,000 $2,459,000
Other Current Liabilities - $100,000 $10,000 $12,000
Other Payable - - - $55,000
Other Non Current Liabilities - - - -
Equity
Common Stock Equity $-7,000,000 $-9,000,000 $6,967,000 $30,607,000
Total Equity Gross Minority Interest $-7,000,000 $-9,000,000 $6,967,000 $30,607,000
Stockholders Equity $-7,000,000 $-9,000,000 $6,967,000 $30,607,000
Other Equity Interest $17,700,000 $14,500,000 - $11,954,000
Retained Earnings $-165,100,000 $-144,700,000 $-178,325,000 $-132,718,000
Long Term Equity Investment $0 $0 $0 $9,000
Investments In Other Ventures Under Equity Method - - - $9,000
Other
Ordinary Shares Number $331,206,012 $154,368,191 $93,781,478 $74,760,432
Share Issued $331,206,012 $154,368,191 $93,781,478 $74,760,432
Tangible Book Value $-7,000,000 $-9,000,000 $6,967,000 $30,607,000
Invested Capital $1,300,000 $-500,000 $18,915,000 $42,949,000
Working Capital $1,000,000 $-5,000,000 $10,746,000 $32,978,000
Capital Lease Obligations $0 $0 $171,000 $0
Total Capitalization $1,300,000 $-4,700,000 $14,452,000 $38,289,000
Additional Paid In Capital $141,300,000 $121,800,000 $186,456,000 $164,012,000
Capital Stock $1,100,000 $500,000 $286,000 $228,000
Common Stock $1,100,000 $500,000 $286,000 $228,000
Current Capital Lease Obligation $0 $0 $130,000 $0
Investmentsin Subsidiariesat Cost $0 $0 - $0
Net PPE $200,000 $200,000 $1,186,000 $1,369,000
Accumulated Depreciation $-300,000 $-300,000 $-850,000 $-509,000
Gross PPE $500,000 $500,000 $2,036,000 $1,878,000
Other Properties $200,000 $200,000 $1,142,000 $1,143,000
Machinery Furniture Equipment $500,000 $500,000 $159,000 $159,000
Buildings And Improvements $0 $0 $735,000 $576,000
Properties $0 $0 $0 $0
Finished Goods $200,000 $300,000 - $1,160,000
Other Short Term Investments $100,000 $700,000 - $2,744,000
Treasury Shares Number - $0 - -
Long Term Capital Lease Obligation - $0 $41,000 $0
Available For Sale Securities - $698,000 $1,460,000 $2,744,000
Pensionand Other Post Retirement Benefit Plans Current - - $3,866,000 $1,437,000
Investmentsin Joint Venturesat Cost - - $0 $9,000
Construction In Progress - - - $0
Fetched: 2026-02-02
Cash Flow Statement (Annual)
Metric 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Free Cash Flow
Free Cash Flow $-17,900,000 $-29,800,000 $-34,085,000 $-46,586,000
Operating Activities
Operating Cash Flow $-17,900,000 $-29,800,000 $-34,085,000 $-45,924,000
Investing Activities
Investing Cash Flow $0 $100,000 $0 $-662,000
Capital Expenditure - $-4,000 - $-662,000
Net Other Investing Changes - - - -
Financing Activities
Issuance Of Capital Stock $19,500,000 $11,900,000 $20,557,000 $9,210,000
Financing Cash Flow $16,000,000 $10,000,000 $16,386,000 $25,630,000
Net Common Stock Issuance $19,500,000 $11,900,000 $20,557,000 $9,210,000
Common Stock Issuance $19,500,000 $11,900,000 $20,557,000 $9,210,000
Other
Repayment Of Debt $-3,500,000 $-1,700,000 $-3,180,000 $0
End Cash Position $3,600,000 $4,700,000 $24,682,000 $41,333,000
Beginning Cash Position $4,700,000 $24,700,000 $41,333,000 $65,128,000
Effect Of Exchange Rate Changes $800,000 $-300,000 $1,048,000 $-2,839,000
Changes In Cash $-1,900,000 $-19,700,000 $-17,699,000 $-20,956,000
Net Issuance Payments Of Debt $-3,500,000 $-1,700,000 $-3,180,000 $18,020,000
Net Long Term Debt Issuance $-3,500,000 $-1,700,000 $-3,180,000 $18,020,000
Long Term Debt Payments $-3,500,000 $-1,700,000 $-3,180,000 $0
Net Investment Purchase And Sale $0 $100,000 - $0
Sale Of Investment $0 $100,000 - $0
Net Business Purchase And Sale $0 $0 - $0
Purchase Of Business $0 $0 - $0
Change In Working Capital $-3,300,000 $-3,300,000 $5,749,000 $-192,000
Change In Payable $-2,700,000 $-4,000,000 $448,000 $1,964,000
Change In Prepaid Assets $-800,000 $200,000 $1,299,000 $-1,487,000
Change In Inventory $100,000 $400,000 - $-807,000
Change In Receivables $100,000 $100,000 $125,000 $-307,000
Other Non Cash Items $3,900,000 $3,800,000 $51,000 $-4,117,000
Stock Based Compensation $3,200,000 $1,100,000 $2,932,000 $4,621,000
Depreciation And Amortization $0 $2,500,000 $508,000 $489,000
Amortization Cash Flow $0 $2,300,000 - $2,309,000
Gain Loss On Investment Securities $500,000 $600,000 $3,281,000 $5,900,000
Net Foreign Currency Exchange Gain Loss $-400,000 $-200,000 $-1,008,000 $-7,340,000
Net Income From Continuing Operations $-21,800,000 $-45,500,000 $-45,607,000 $-45,276,000
Net PPE Purchase And Sale - $-4,000 $0 $-557,000
Purchase Of PPE - $-4,000 $0 $-557,000
Change In Other Current Assets - $0 $29,000 $-75,000
Change In Accrued Expense - $-4,054,000 $3,848,000 $-234,000
Depreciation - $200,000 $508,000 $489,000
Issuance Of Debt - - $0 $18,020,000
Long Term Debt Issuance - - $0 $18,020,000
Net Intangibles Purchase And Sale - - $0 $-105,000
Purchase Of Intangibles - - $0 $-105,000
Change In Other Current Liabilities - - $0 $-53,000
Gain Loss On Sale Of Business - - $0 $0
Interest Received Cfi - - - $0
Purchase Of Investment - - - $0
Interest Received Cfo - - - -
Fetched: 2026-02-02